↗4 Form 4 rows in the window
Covers original filings from Aug 1, 2026 to Oct 29, 2026. Older trades and amendments are in the SEC history.
$0.00Bought on the market
$402KSold on the market
1Companies
Sep 22, 2026Latest filing
| Company | Title | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 22, 202618:48 | Sep 21, 2026 | MLYSMineralys Therapeutics, Inc. | Chief Commercial Officer | S · Sell10b5-1 | $28.12 | −7,438 | 38,400 | -16% | −$209K | ||
| Sep 22, 202618:48 | Sep 21, 2026 | MLYSMineralys Therapeutics, Inc. | Chief Commercial Officer | M · Exercise10b5-1 | $13.24 | +7,438 | 45,838 | +19% | $98K | ||
| Aug 25, 202617:16 | Aug 21, 2026 | MLYSMineralys Therapeutics, Inc. | Chief Commercial Officer | S · Sell10b5-1 | $25.98 | −7,437 | 38,400 | -16% | −$193K | ||
| Aug 25, 202617:16 | Aug 21, 2026 | MLYSMineralys Therapeutics, Inc. | Chief Commercial Officer | M · Exercise10b5-1 | $13.24 | +7,437 | 45,837 | +19% | $98K |